Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × ARQ 197 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 3 Solid Tumors 2 Melanoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Neoplasm 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Renal Insufficiency 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteolysis 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Malignant Solid Tumour 1 Liver Neoplasms 1 Hypercalcemia 1 Hematologic Neoplasms 1 Fractures, Spontaneous 1 Fibrosis 1 Colorectal Neoplasms 1

Interventions

Sorafenib 39 Bevacizumab 14 Oxaliplatin 13 Leucovorin 9 Fluorouracil 9 Doxorubicin 9 Radiofrequency Ablation 8 Hepatectomy 8 Gemcitabine 8 Cisplatin 8 Capecitabine 8 Radiosurgery 7 pembrolizumab 6 Nivolumab 6 Irinotecan 6 Drug Therapy 6 Cryosurgery 6 Carboplatin 6 Talaporfin 5 Mitomycin 5 spartalizumab 4 Melphalan 4 Everolimus 4 Erlotinib Hydrochloride 4 Embolization, Therapeutic 4 Electroporation 4 aldesleukin 3 Surveys and Questionnaires 3 Sunitinib 3 Sirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02029157 2017-10-09

JET-HCC

Kyowa Kirin Co., Ltd.

Phase 3 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡